{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:38:31Z","timestamp":1791545911825,"version":"4.3.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fundaci\u00f3n para la Investigaci\u00f3n La Fe","award":["2013\/0332"],"award-info":[{"award-number":["2013\/0332"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI12\/0946"],"award-info":[{"award-number":["PI12\/0946"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00415-016-8223-z","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T07:45:33Z","timestamp":1467791133000},"page":"1954-1960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Safety and efficacy of botulinum toxin A for the treatment of spasticity in amyotrophic lateral sclerosis: results of a pilot study"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-7938","authenticated-orcid":false,"given":"Juan F.","family":"V\u00e1zquez-Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"M\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Alabajos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maricruz","family":"Guevara Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Roda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,6]]},"reference":[{"key":"8223_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/practneurol-2011-000155","volume":"12","author":"A Kheder","year":"2012","unstructured":"Kheder A, Nair KPS (2012) Spasticity: pathophysiology, evaluation and management. Pract Neurol 12:289\u2013298. doi: 10.1136\/practneurol-2011-000155","journal-title":"Pract Neurol"},{"key":"8223_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/jnnp-2012-302315","volume":"83","author":"M Swash","year":"2012","unstructured":"Swash M (2012) Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry 83:659\u2013662. doi: 10.1136\/jnnp-2012-302315","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8223_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1212\/01.wnl.0000200962.94777.71","volume":"66","author":"PH Gordon","year":"2006","unstructured":"Gordon PH, Cheng B, Katz IB et al (2006) The natural history of primary lateral sclerosis. Neurology 66:647\u2013653. doi: 10.1212\/01.wnl.0000200962.94777.71","journal-title":"Neurology"},{"key":"8223_CR4","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","volume":"82","author":"A Chi\u00f2","year":"2011","unstructured":"Chi\u00f2 A, Calvo A, Moglia C et al (2011) Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 82:740\u2013746. doi: 10.1136\/jnnp.2010.235952","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8223_CR5","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1177\/0269215513491274","volume":"27","author":"JA Baker","year":"2013","unstructured":"Baker JA, Pereira G (2013) The efficacy of botulinum toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the grades of recommendation, assessment, development and evaluation approach. Clin Rehabil 27:1084\u20131096. doi: 10.1177\/0269215513491274","journal-title":"Clin Rehabil"},{"key":"8223_CR6","doi-asserted-by":"publisher","first-page":"g4737","DOI":"10.1136\/bmj.g4737","volume":"349","author":"KPS Nair","year":"2014","unstructured":"Nair KPS, Marsden J (2014) The management of spasticity in adults. BMJ 349:g4737. doi: 10.1136\/bmj.g4737","journal-title":"BMJ"},{"key":"8223_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/NRE-131021","volume":"34","author":"D Cioncoloni","year":"2014","unstructured":"Cioncoloni D, Taddei S, Bielli S et al (2014) Meaningful improvement in walking performance after botulinum neurotoxin A (BoNT-A) in chronic spastic patients. NeuroRehabilitation 34:185\u2013192. doi: 10.3233\/NRE-131021","journal-title":"NeuroRehabilitation"},{"key":"8223_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2016.01.005","author":"A Alabajos Cea","year":"2016","unstructured":"Alabajos Cea A, M\u00e1\u00f1ez A\u00f1\u00f3n I, Roda Alcayde C et al (2016) Decreased spasticity in primary lateral sclerosis after botulinum toxin injection: a case report. Neurologia. doi: 10.1016\/j.nrl.2016.01.005","journal-title":"Neurologia"},{"key":"8223_CR9","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1212\/01.wnl.0000243812.25517.87","volume":"67","author":"F Kimura","year":"2006","unstructured":"Kimura F, Fujimura C, Ishida S et al (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 67:1314\u20131315. doi: 10.1212\/01.wnl.0000243812.25517.87 (author reply 1314\u20135)","journal-title":"Neurology"},{"key":"8223_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13\u201321","journal-title":"J Neurol Sci"},{"key":"8223_CR11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ptj\/72.2.115","volume":"72","author":"JM Florence","year":"1992","unstructured":"Florence JM, Pandya S, King WM et al (1992) Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne\u2019s muscular dystrophy. Phys Ther 72:115\u2013122 (discussion 122\u20136)","journal-title":"Phys Ther"},{"key":"8223_CR12","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/01.STR.26.6.982","volume":"26","author":"J Perry","year":"1995","unstructured":"Perry J, Garrett M, Gronley JK, Mulroy SJ (1995) Classification of walking handicap in the stroke population. Stroke 26:982\u2013989","journal-title":"Stroke"},{"key":"8223_CR13","doi-asserted-by":"publisher","unstructured":"Ashworth NL, Satkunam LE, Deforge D (2006) Treatment for spasticity in amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database Syst Rev CD004156. doi: 10.1002\/14651858.CD004156.pub4","DOI":"10.1002\/14651858.CD004156.pub4"},{"key":"8223_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","volume":"19","author":"PM Andersen","year":"2012","unstructured":"Andersen PM, Abrahams S, Borasio GD et al (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)\u2013revised report of an EFNS task force. Eur J Neurol 19:360\u2013375. doi: 10.1111\/j.1468-1331.2011.03501.x","journal-title":"Eur J Neurol"},{"key":"8223_CR15","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s00415-013-6854-x","volume":"260","author":"L Kent","year":"2013","unstructured":"Kent L, Davies P, Kennett R et al (2013) Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy. J Neurol 260:1166\u20131167. doi: 10.1007\/s00415-013-6854-x","journal-title":"J Neurol"},{"key":"8223_CR16","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1212\/WNL.0b013e318281cc1b","volume":"80","author":"DA Restivo","year":"2013","unstructured":"Restivo DA, Zappia M, Elia M, Romano MC (2013) ALS dysphagia pathophysiology. Differential botulinum toxin response. Neurology 80:616\u2013620. doi: 10.1212\/WNL.0b013e318281cc1b","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8223-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8223-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8223-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:55:07Z","timestamp":1498312507000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8223-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,6]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["8223"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8223-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,6]]}}}